Valuation: BML, Inc.

Market Cap 138B 874M 762M 717M 653M 1.22B 83.69B 1.23B 8.59B 3.31B 42.63B 3.28B 3.21B P/E 2027 *
18.3x
P/E 2028 * 15.9x
Enterprise Value 138B 874M 762M 717M 653M 1.22B 83.69B 1.23B 8.59B 3.31B 42.63B 3.28B 3.21B EV / Sales 2027 *
0.89x
EV / Sales 2028 * 0.86x
Free-Float
49.65%
Yield 2027 *
3.41%
Yield 2028 * 3.81%
1 day+4.59%
Current year+0.99%
Current year 24.1
Extreme 24.1
25.21
1 year 24.1
Extreme 24.1
25.21
3 years 18.2
Extreme 18.2
25.21
5 years 18.2
Extreme 18.2
25.21
10 years 18.2
Extreme 18.2
25.21
Manager TitleAgeSince
President 60 2013-12-31
Corporate Officer/Principal 61 2020-03-31
Corporate Officer/Principal 66 2014-03-31
Director TitleAgeSince
Director/Board Member 60 2006-05-31
Director/Board Member 64 2016-05-31
Director/Board Member 68 2025-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.59%-.--% - - 876M
+0.34%+8.44%+104.65%+683.76% 53.25B
+0.09%+1.80%+15.77%+56.47% 26.01B
-1.95%-1.34%-14.20%-37.61% 6.76B
-4.38%-3.74%-4.93%+166.19% 5.98B
+0.36%+1.23%+13.90%+64.97% 3.3B
-3.23%+9.01%-24.52%+2,580.27% 3.02B
-2.51%+5.43%+127.82%+59.10% 2.56B
+17.67%+2.71%+37.63%+47.22% 2.25B
+2.68%+4.66%-6.29%-53.90% 1.91B
Average +1.03%+4.82%+27.76%+396.28% 11.67B
Weighted average by Cap. -0.72%+7.31%+59.30%+445.25%

Financials

2027 *2028 *
Net sales 155B 985M 859M 809M 737M 1.38B 94.35B 1.38B 9.69B 3.73B 48.06B 3.7B 3.62B 160B 1.02B 887M 835M 761M 1.43B 97.46B 1.43B 10B 3.86B 49.64B 3.82B 3.74B
Net income 7.4B 46.99M 40.97M 38.59M 35.14M 65.89M 4.5B 65.97M 462M 178M 2.29B 177M 173M 8.2B 52.07M 45.4M 42.76M 38.94M 73.01M 4.99B 73.1M 512M 197M 2.54B 196M 191M
Net Debt - -
Logo BML, Inc.
BML Inc is a Japan-based company primarily engaged in the testing business. Data processed in the host core system is reported to customers as test results. Customer unit price data and specimen testing performance data held by the host core system become billing data for customers, which is then linked to the automatic recording of sales. Other businesses include the medical information systems business. The testing business segment undertakes contract work such as clinical testing, while the medical information systems business segment manufactures and sells system equipment for medical institutions and provides medical information services.
Employees
4,612
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3,670.00JPY
Average target price
3,800.00JPY
Spread / Average Target
+3.54%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!